Pediatric Drug Research & the FDA
Congress reauthorized two laws in 2007, the Pediatric Research Equity Act (PREA) and the Best Pharmaceuticals for Children Act (BPCA). PREA requires that sponsors conduct pediatric studies for certain products unless the Department of Health and Human Services' (HHS) Food and Drug Administration (FDA) grants a waiver or deferral. On June 20th, 2012, the House of Representatives passed, by voice vote and under suspension of the rules, the Food and Drug Administration Safety and Innovation Act, as amended. This bill would reauthorize the FDA prescription drug and medical device user fee programs, create new user fee programs for generic and bio…
Mehr
CHF 139.00
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
V105:
Folgt in ca. 15 Arbeitstagen
Produktdetails
Weitere Autoren: Bennett, Jeff E (Hrsg.)
- ISBN: 978-1-62257-729-3
- EAN: 9781622577293
- Produktnummer: 17670506
- Verlag: Nova Science Publishers Inc
- Sprache: Englisch
- Erscheinungsjahr: 2013
- Seitenangabe: 95 S.
- Masse: H15.3 cm x B22.9 cm x D0.7 cm 156 g
- Gewicht: 156
- Sonstiges: Postgraduate, Research & Scholarly
Bewertungen
Anmelden